 |
인쇄하기
취소
|
MSD Korea, CJ to co-market Singulair
CJ Cheil Jedang and MSD Korea announced on September 22 that the two companies have signed an agreement to co-market Singulair (montelukast sodium) in Korea.
Singulair is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.
Underscoring the important synergy created by this partnership, Lee Jong-ho, managing director w...
Singulair is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.
Underscoring the important synergy created by this partnership, Lee Jong-ho, managing director w...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.